Multiple rectal neuroendocrine tumors: An analysis of 15 cases and literature review

Shu Pang1, Ye Zong2, Kun Zhang3

  • 1Department of General Practice, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

Frontiers in Oncology
|October 3, 2022
PubMed

Insights

Rectal neuroendocrine tumors (M-NETs) are rare and often asymptomatic. Despite small size, M-NETs carry a high metastasis risk, necessitating aggressive treatment and surveillance strategies.

Area of Science:

  • Gastroenterology
  • Oncology
  • Pathology

Background:

  • Multiple neuroendocrine tumors (M-NETs) of the rectum are rare, with limited understanding of their characteristics and optimal treatment.
  • Current consensus on rectal M-NETs management is lacking.

Purpose of the Study:

  • To analyze the clinical, endoscopic, and pathological features of rectal M-NETs.
  • To evaluate treatment and follow-up strategies for rectal M-NETs based on their characteristics.

Main Methods:

  • Retrospective analysis of 15 patients diagnosed with rectal M-NETs at Beijing Friendship Hospital.
  • Review of clinical data, endoscopic findings, pathological features, and treatment outcomes.
  • Literature review of previous studies on rectal M-NETs.

Main Results:

  • 14 males and 1 female were included, with an average age of 55.7 years.
  • Most tumors (86.7%) were ≤10mm, originating from the mucosa or submucosa, and were WHO grade NET G1.
  • Lymphovascular invasion was observed in 60% of patients, and 6.7% had lymph node metastasis, indicating a high risk of spread.
  • Endoscopic resection was performed in 14 patients, with no recurrence or metastasis reported during follow-up.

Conclusions:

  • Rectal M-NETs, even small ones, have a significant risk of lymphovascular invasion and metastasis.
  • Pathological diagnosis may reveal more lesions than initially observed endoscopically.
  • More radical treatment and surveillance approaches are recommended for rectal M-NETs compared to single lesions.